Delivery Order SPE2DB20D1100-SPE2DB24FC3W0
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,052.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,826,397 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The award has an ultimate completion date of April 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,571.30, is for the delivery of 4,567,909,043 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The award did not have a set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,872.98, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award, valued at $1,005.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,517,461 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a completion date of November 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,515.78 firm fixed-price delivery order is for the supply of 4,564,327,287 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of April 19, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,169.21, is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count quantities. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.36 firm fixed-price delivery order is for the supply of 4,567,461,943 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, a medication used for the treatment of various gastrointestinal conditions. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,049.48 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a total ceiling value of $2,015.40 and a performance period ending on April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,292.92, is for the delivery of 4,568,174,061 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a firm-fixed-price delivery order, with a performance period extending through May 8, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a...